Singapore markets open in 3 hours 48 minutes

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.8700+0.0300 (+0.78%)
At close: 04:00PM EDT
3.8700 0.00 (0.00%)
After hours: 04:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 323.42M
Enterprise value -215.86M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.64
Enterprise value/revenue 58.97
Enterprise value/EBITDA -260.47

Trading information

Stock price history

Beta (5Y monthly) 0.18
52-week change 34.63%
S&P500 52-week change 324.13%
52-week high 34.6000
52-week low 32.7650
50-day moving average 33.6248
200-day moving average 33.5371

Share statistics

Avg vol (3-month) 3267.85k
Avg vol (10-day) 3241.97k
Shares outstanding 584.22M
Implied shares outstanding 684.75M
Float 864.42M
% held by insiders 19.58%
% held by institutions 166.89%
Shares short (28 Jun 2024) 42.24M
Short ratio (28 Jun 2024) 47.64
Short % of float (28 Jun 2024) 43.74%
Short % of shares outstanding (28 Jun 2024) 42.66%
Shares short (prior month 31 May 2024) 42.18M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-15.56%
Return on equity (ttm)-29.16%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -147.83M
Net income avi to common (ttm)-163.66M
Diluted EPS (ttm)-1.9500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)541.49M
Total cash per share (mrq)6.43
Total debt (mrq)2.21M
Total debt/equity (mrq)0.44%
Current ratio (mrq)13.28
Book value per share (mrq)5.99

Cash flow statement

Operating cash flow (ttm)-95.41M
Levered free cash flow (ttm)-9.22M